about
Leukemia inhibitory factor, a cytokine at the interface between neurobiology and immunologyCentral nervous system neurons acquire mast cell products via transgranulationDiagnosis of acute basophilic leukemiaMast cell activation syndromes: definition and classification.IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditionsPerinatal stress, brain inflammation and risk of autism-review and proposal.Anaphylactic shock: mechanisms and treatmentImmune system control of rat and rabbit colonic electrolyte transport. Role of prostaglandins and enteric nervous systemCorticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process.Involvement of tachykinin receptors in sensitisation to cow's milk proteins in guinea pigs.Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposalMast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease.Mast cell modulation of tumour cell proliferation in rat mammary adenocarcinoma 13762NFPrinciples of pharmacotherapy: III. Drug allergy.Chronic Inflammation: Synergistic Interactions of Recruiting Macrophages (TAMs) and Eosinophils (Eos) with Host Mast Cells (MCs) and Tumorigenesis in CALTs. M-CSF, Suitable Biomarker for Cancer Diagnosis!Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria.Lipid mediators of inflammatory and immune reactions.Phenotypic characteristics of acute megakaryocytic leukemia and transient abnormal myelopoiesis.Tumor necrosis factor alpha promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxis.Molecular and functional characterization of the urokinase receptor on human mast cells.Therapeutic controversies in the management of acute anaphylaxis.Role of 5-hydroxytryptamine in intestinal water and electrolyte movement during gut anaphylaxis.Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels.Management of respiratory complications in clinical dental practice. Pathophysiological and technical considerations.Transgenic mice expressing the human high-affinity immunoglobulin (Ig) E receptor alpha chain respond to human IgE in mast cell degranulation and in allergic reactions.Quantitative, phenotypic, and functional evaluation of basophils in myelodysplastic syndromes.Mast cells in Wallerian degeneration: morphologic and ultrastructural changes.Inhibitory effect of retinoic acid on proliferation, maturation and tryptase level in human leukemic mast cells (HMC-1).The effect of a herbal water-extract on histamine release from mast cells and on allergic asthma.Influence of interleukin-1 receptor antagonist on [3H]serotonin and histamine release by rat basophilic leukemia-2H3 cells.Specific inhibition of immunoglobulin E-mediated allergic reaction using antisense Fc epsilon RI alpha oligodeoxynucleotides.Suppression of Th2-type immune response-mediated allergic diarrhea following oral administration of traditional Korean medicine: Atractylodes macrocephala Koidz.Vesicular monoamine transporter 2 (VMAT2) expression in hematopoietic cells and in patients with systemic mastocytosis.The Fab fragment of anti-IgE Cε2 domain prevents allergic reactions through interacting with IgE-FcεRIα complex on rat mast cells
P2860
Q24564233-555621EC-2F3C-4660-AD95-FDD36321FED6Q24631650-9AF68C9C-1488-450B-B370-53808EF24ABFQ28137752-3571F6DB-3141-4993-A2AC-6BB49BE17BE0Q34035582-6412662A-CF11-4100-917A-C0419CA40ED3Q34038230-5A5700F9-3CE0-4D58-A662-68A52876DD6BQ34285045-C378700A-E9E0-40B0-8DE4-A9A26E0C1C87Q34291277-4767C227-9645-428B-BB21-98C92F292944Q34574098-33CBDC46-15F8-4FD4-A58A-6761A2E7644EQ34650833-71CE8C85-13D9-4332-A7FF-4A87DA9084A8Q35354798-C1161FC1-2E1C-40C5-8055-284F4481959AQ35574171-D89483AB-1608-4E81-B7C7-230552AD0400Q35841400-704083E0-8457-46B2-9DF9-2F2A378F90B9Q35984781-669CA3E5-442E-46DF-9016-3E7766EFAA11Q36313040-54C4284A-383D-4BCB-AA7A-D8754FE1E2D9Q37693490-98BA460F-0184-4349-89BE-14548CAFA090Q37876117-C83C3D4D-14AE-41EA-8612-6E5DF9CBA2FFQ39555618-ADF225E7-8CE2-4DFF-BACE-085FD3D27A95Q40693866-5DAA0337-49DB-457B-8E93-9AA64384FE4CQ40904867-F9C5BB33-3980-491D-823D-057C158EE5F5Q41120291-A8203178-A9BE-4D05-8958-C9AD13147F1CQ41756400-366B788D-A463-4DB4-95DE-06A23FAEEE7EQ41859583-EFDCBEAD-017E-4726-ACD5-818B87CA93BCQ42198666-0CC96EBF-F53A-43EB-BED4-AD456E57052AQ42720941-6A7E03B8-A1D7-4DF0-A1E2-2ECF28AE56EAQ42943300-4EFEB9FE-9BF4-4849-ADB4-704CBC10F204Q43818029-397595A1-EE45-48FA-98DA-4FD4C5C6A080Q43938115-4BDABEA5-E253-4058-8CA6-37BC00868E98Q44309968-8942BAAB-E0D5-4074-A6C2-BB0434CA3098Q44995329-4A61076F-0D90-4321-9F44-A6B82E7E5300Q47687978-1E4C7B02-2546-4185-A537-197B62D92143Q47864898-32F3C52B-1248-4C7E-AE66-D058689C283EQ53660376-EE280F46-2616-440E-8BB7-7B18DD900FF1Q54647310-86889125-FECB-4FDF-A437-0BCE573A032DQ58700697-3CDEF594-9B05-4E6C-8762-C558DC8E459A
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mediators of immediate hypersensitivity reactions.
@en
type
label
Mediators of immediate hypersensitivity reactions.
@en
prefLabel
Mediators of immediate hypersensitivity reactions.
@en
P1476
Mediators of immediate hypersensitivity reactions.
@en
P2093
P356
10.1056/NEJM198707023170106
P407
P577
1987-07-01T00:00:00Z